Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.
about
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL.Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.Predictive gene signatures determine tumor sensitivity to MDM2 inhibition.
P2860
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@en
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@nl
type
label
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@en
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@nl
prefLabel
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@en
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@nl
P2093
P2860
P1433
P1476
Dysfunctional diversity of p53 ...... diagnostic workup and therapy.
@en
P2093
Alina Molchadsky
Miron Prokocimer
Varda Rotter
P2860
P304
P356
10.1182/BLOOD-2017-02-763086
P407
P577
2017-06-12T00:00:00Z